| Clinical data | |
|---|---|
| Routes of administration | By mouth |
| Drug class | Stimulant |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C10H14FN |
| Molar mass | 167.227 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
2-Fluoromethamphetamine (2-FMA) is astimulant drug of theamphetamine family which has been used as adesigner drug.[2][3][4] 2-FMA is commonly compared tolisdexamfetamine (Vyvanse), anddextroamphetamine due to its efficacy as a study or productivity aid.[citation needed] 2-FMA is purported to produce somewhat less euphoria than comparable amphetamines, likely due to its main mechanism of action consisting ofnorepinephrine reuptake inhibition.[5][failed verification]
2-Fluoromethamphetamine is fluorinated analogue ofmethamphetamine, and is aregioisomer of3-FMA and4-FMA.
It does not activate the serotonin receptors, including5-HT2A,[5] unlike most stimulant drugs of the amphetamine family.
As of 1996, 2-FMA is a controlled substance in Canada, due to being an analog ofmethamphetamine.[1]
As of October 2015, 2-FMA is a controlled substance in China.[6]
As of 13 December 2014, 2-FMA is a controlled substance in Germany.[7] It is controlled under Anlage I BtMG (Narcotics Act, Schedule I).[8] Substances controlled under Anlage I BtMG are illegal to manufacture, possess, import, export, buy, sell, procure or dispense without a license. Violations of the law are punishable by a fine or imprisonment for up to five years.[9]
As of July 2019, 2-FMA is a controlled substance in Ukraine (considered a narcotic).[10]
As a close analog ofscheduledcontrolled substance,[2] sale orpossession of 2-FMA could be potentially be prosecuted under theFederal Analogue Act.[11]